RIDGEFIELD, CT, USA I 9, 2024 I Boehringer Ingelheim reports positive results from a Phase Ib primary analysis of Cohort 1 of the Beamion LUNG-1 ...
11d
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...
Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D ...
There have been tens of thousands of lawsuits since 2020 and there are no doubt many more in the pipeline but few have gone to trial ... unable to decide whether German pharmaceutical Boehringer ...
With the acquisition, Boehringer Ingelheim strengthens its animal health research and development (R&D) pipeline, specifically in the fast-growing pet therapeutics category. As life expectancy for ...
With the acquisition, Boehringer Ingelheim strengthens its animal health research and development (R&D) pipeline, specifically in the fast-growing pet therapeutics category. As life expectancy for ...
Nilesh Gupta, managing director, Lupin. G lobal pharma leader Lupin has a robust pipeline lined up for FY25—over 25+ projects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback